What Researchers Did
Researchers conducted a retrospective study of 55 brain abscess patients at an Austrian university hospital, comparing 25 who received adjunctive HBOT alongside standard antibiotics and surgery versus 30 who received standard therapy alone.
What They Found
At 6 months, 80% of HBOT patients had complete imaging resolution versus 46.7% of controls (p=0.009). At 12 months, 60% of HBOT patients were symptom-free versus 30% of controls (p=0.046). Mortality at 12 months was 12% in the HBOT group versus 20% in controls. No HBOT-related adverse events occurred.
What This Means for Canadian Patients
Brain abscess carries significant risk of death and permanent neurological damage even with surgery and antibiotics. This study suggests HBOT can meaningfully improve both imaging and functional outcomes. Canadians with brain abscesses not responding to standard treatment should ask their neurosurgeon whether HBOT is available nearby.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a retrospective study from a single center; patients were not randomized, so HBOT recipients may have been selected based on factors that independently affected their outcomes.